Concepedia

Peifen Fu

PF

10

Publications

531

Citations

10

H-Index

2014

Active since

Affiliations

First Affiliated Hospital Zhejiang University(Current)

Peking University

Qingdao University

Zhejiang University

Hebei Medical University

Peifen Fu is an author at First Affiliated Hospital Zhejiang University specializing in medicine, breast cancer, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2024

10

Publications

10

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Zefei Jiang, Quchang Ouyang, Tao Sun et al. · Nature Medicine · 2024 · 90 citations

, , +6

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer

Peifen Fu, Minya Yao, Yu Liu et al. · OncoTargets and Therapy · 2014 · 82 citations · Full text

Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway

Jie Pan, Jiaying Shen, Wengong Si et al. · Oncotarget · 2017 · 72 citations · Full text

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

Jiong Wu, Zefei Jiang, Zhenzhen Liu et al. · BMC Medicine · 2022 · 70 citations · Full text

Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways

Shuqian Wang, Yinan Yao, Minya Yao et al. · Biochemical and Biophysical Research Communications · 2018 · 59 citations

, , +10

Rows per page

1–5 of 10